First, although we have revealed that the BIP-IRE-1α pathway in the ACC was activated after peripheral nerve injury, that both the antagonists of BIP and IRE-1α mitigated CCI-induced NP, and that the activation of this pathway induces pain hypersensitivity, the mechanisms underlying ERS mediating NP were not well-addressed. The gene discussed is ERN1; the disease is peripheral nerve injury.